Advertisement

Biomedical Ethics

In an interview with “EWTN News Nightly” anchor Tracy Sabol, National Catholics Bioethics Center President Dr. Joseph Meaney discusses the first-ever therapy approved by the FDA using CRISPR, a genome editing technology. | Credit: “EWTN News Nightly”

"Groundbreaking" Gene-editing Therapy Receives Thumbs up from Catholic Bioethicist

Dec 12, 2023

A new gene-editing therapy designed to help treat patients suffering from sickle cell disease has been endorsed by the National Catholic Bioethics Center.

Shutterstock

21 International Doctors Sign Open Letter Against Youth Transgender "transition" Procedure

Jul 14, 2023

A group of 21 doctors from countries around the world wrote publicly on Thursday that the ongoing push to provide young children with transgender “transition” procedures is unsupported by current evidence and that medical officials should shift their approaches to managing youth gender dysphoria.